原发性肾素分泌对血管紧张素转换酶抑制的反应。
Primary renal renin secretion responding to angiotensin converting enzyme inhibition.
作者信息
Newrick P G, Millar N, Penney M, Corrall R J
机构信息
Department of Medicine, Bristol Royal Infirmary, UK.
出版信息
Postgrad Med J. 1992 Aug;68(802):686-8. doi: 10.1136/pgmj.68.802.686.
Abstract
A case of primary renal renin secretion of probable neoplastic origin is reported. Investigation demonstrated renin secretion to be incompletely autonomous with suboptimal suppression to posture and hypervolaemia. Easy control of the hypertension and hypokalaemia was achieved with an angiotensin converting enzyme inhibitor. Such treatment may prove to be a preferable option to surgery.
摘要
报告了一例可能起源于肿瘤的原发性肾素分泌病例。研究表明，肾素分泌并非完全自主，对体位和血容量过多的抑制效果欠佳。使用血管紧张素转换酶抑制剂可轻松控制高血压和低钾血症。这种治疗方法可能被证明是比手术更可取的选择。
相似文献
1
Primary renal renin secretion responding to angiotensin converting enzyme inhibition.原发性肾素分泌对血管紧张素转换酶抑制的反应。
Postgrad Med J. 1992 Aug;68(802):686-8. doi: 10.1136/pgmj.68.802.686.
2
A renin-secreting tumour sensitive to changes in central blood volume (presumably via sympathetics) but not to circulating angiotensin II.一种对中心血容量变化敏感（可能通过交感神经）但对循环中的血管紧张素II不敏感的分泌肾素的肿瘤。
Clin Exp Pharmacol Physiol. 1990 Mar;17(3):185-9. doi: 10.1111/j.1440-1681.1990.tb01303.x.
3
[Renal protection with antagonists of the angiotensin II receptors].[血管紧张素 II 受体拮抗剂的肾脏保护作用]
Med Clin (Barc). 2000;114 Suppl 1:29-33.
4
Renin inhibition: what are the clinical perspectives?
Semin Nephrol. 2007 Sep;27(5):511-8. doi: 10.1016/j.semnephrol.2007.07.006.
5
Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.通过抑制血管紧张素转换酶使高血压转基因大鼠TGR(mRen-2)27被抑制的肾素水平逆转。
Am J Hypertens. 1995 Oct;8(10 Pt 1):1031-9. doi: 10.1016/0895-7061(95)00270-7.
6
Renal and cardio-protective effects of direct renin inhibition: a systematic literature review.直接肾素抑制的肾和心脏保护作用：系统文献综述。
J Hypertens. 2009 Dec;27(12):2321-31. doi: 10.1097/HJH.0b013e3283310f92.
7
Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.肾素-血管紧张素-醛固酮系统抑制：血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂、盐皮质激素受体拮抗剂及直接肾素抑制剂治疗用途概述
Prim Care. 2014 Dec;41(4):765-78. doi: 10.1016/j.pop.2014.08.002. Epub 2014 Sep 29.
8
[Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].[自发性高血压大鼠中血管紧张素转换酶抑制血管紧张素I时的肾组织血管紧张素]
Arch Mal Coeur Vaiss. 1997 Aug;90(8):1135-41.
9
[For which hypertensive patient should angiotensin-converting enzyme inhibitor be prescribed or forbidden?].[哪些高血压患者应该使用血管紧张素转换酶抑制剂，哪些应该禁用？]
Rev Prat. 1992 Dec 15;42(20):2545-9.
10
Is there benefit in dual renin-angiotensin-aldosterone system blockade? No, yes and maybe: a guide for the perplexed.双重肾素-血管紧张素-醛固酮系统阻断是否有益？否，是，也许是：一个困惑的指南。
Diab Vasc Dis Res. 2013 May;10(3):193-201. doi: 10.1177/1479164112463710. Epub 2013 Jan 24.
本文引用的文献
1
The radiology of juxtaglomerular tumors.球旁细胞瘤的放射学
Radiology. 1983 May;147(2):321-6. doi: 10.1148/radiology.147.2.6836111.
2
Hypertension due to a renin-secreting renal tumour.肾素分泌性肾肿瘤所致高血压
Am J Med. 1967 Dec;43(6):963-76. doi: 10.1016/0002-9343(67)90256-2.
3
Primary reninism with renal hamartomatous alteration.伴有肾错构瘤样改变的原发性肾素增多症。
JAMA. 1974 Dec 2;230(9):1288-92.
4
Impaired sodium excretion in response to volume expansion induced by water immersion in insulin-dependent diabetes mellitus.
Clin Sci (Lond). 1986 Oct;71(4):403-9. doi: 10.1042/cs0710403.
5
Atrial natriuretic peptide: physiological release associated with natriuresis during water immersion in man.
Clin Sci (Lond). 1986 Sep;71(3):319-22. doi: 10.1042/cs0710319.
Zotero 插件